The Valley Desk

NCT02279719 · Interventional trial

A Study of BBI608 in Combination With Sorafenib, or BBI503 in Combination With Sorafenib in Adult Patients With Hepatocellular Carcinoma

Overall registry status Completed

Phase 1 · Phase 2

Conditions Hepatocellular Carcinoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov